Table 2 Results of patient surveys administered in GI-CREP clinic
All Participants (N = 66) | Telemedicine (N = 36) | In-Person Office Visit (N = 30) | p value | |
|---|---|---|---|---|
Previously tested positive for COVID-19 | 3 (5%) | 1 (3%) | 2 (7%) | 0.587 |
Received a COVID-19 vaccine | 58 (88%) | 33 (92%) | 25 (83%) | 0.453 |
Previously used telemedicine | 56 (85%) | 31 (86%) | 25 (83%) | 1 |
Had a preference for either a telemedicine or in-person visit (independent of visit type scheduled) | 57 (86%) | 32 (89%) | 25 (83%) | 0.721 |
Prefer telemedicine (of those with a visit preference) | 31 (97%) | 13 (52%) | 0.0001 | |
Prefer in-person (of those with a visit preference) | 1 (3%) | 12 (48%) | ||
Visit met expectations | 65 (99%) | 36 (100%) | 29 (97%) | 0.455 |